The aim of this study is to evaluate site-specific CDKN2A methylation patterns in both tumor and matched non-neoplastic tissues, amplification conditions and to propose a threshold value for CDKN2A methylation “positivity” by pyrosequencing. The gene discussed is CDKN2A; the disease is neoplasm.